Takayuki Enomoto

35PUBLICATIONS
160CO-AUTHORS
Predictive and prognostic markersPreventative health careCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingOther Asian languages (excl. South-East Asian)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 07, 2026
Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026).

|Oct 26, 2024
Human papillomavirus vaccine to prevent CIN3 or worse (CIN3+): A nationwide case-control study in Japan.

Sayaka Ikeda, Yutaka Ueda, Asami Yagi

|Apr 12, 2024
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT).

Yusuke Kobayashi, Muneaki Shimada, Masato Tamate

|Mar 08, 2024
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan.

Hiroko Machida, Koji Matsuo, Takahiro Higashi

|Sep 17, 2023
SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma.

Hidehiko Akashi, Nozomi Yachida, Haruka Ueda

|Aug 18, 2023
East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.

Takayuki Enomoto, Aikou Okamoto, Jae-Hoon Kim

Pageof 6

Frequent Collaborators

10 joint publications

Mikio Mikami

10 joint publications

Aikou Okamoto

9 joint publications

Daisuke Aoki

8 joint publications

Masayuki Sekine